MSI-H Solid Malignant Tumor
3 clinical trials · Condition
◉ Watch MSI-H Solid Malignant Tumor
| Record | Firm | Date |
|---|---|---|
| A Beta-only IL-2 ImmunoTherapY Study (NCT05086692) | Medicenna Therapeutics, Inc. | 2021-08-27 |
| Combination Immunotherapy in Rare Cancers Under InvesTigation (NCT04969887) | Olivia Newton-John Cancer Research Institute | 2021-08-03 |
| A Clinical Study to Evaluate HLX10 Monotherapy for the Treatment of MSI-H or dMMR Solid Tumors That Failed to Respond to Standard Therapy (NCT03941574) | Shanghai Henlius Biotech | 2019-07-15 |
Track MSI-H Solid Malignant Tumor automatically
Every clearance here is in the API, with alerts when new ones post.